Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,117 | 138 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SPR Therapeutics, Inc | $445.19 | 28 | $0 (2024) |
| Forte Bio-Pharma LLC | $428.21 | 7 | $0 (2024) |
| Boston Scientific Corporation | $413.64 | 11 | $0 (2024) |
| Nevro Corp. | $339.60 | 10 | $0 (2024) |
| Medtronic, Inc. | $321.83 | 5 | $0 (2022) |
| Medtronic USA, Inc. | $236.72 | 7 | $0 (2019) |
| Amgen Inc. | $211.54 | 2 | $0 (2019) |
| Depomed, Inc. | $178.26 | 11 | $0 (2017) |
| Averitas Pharma Inc. | $159.67 | 6 | $0 (2024) |
| Jazz Pharmaceuticals Inc. | $158.49 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $913.89 | 25 | Forte Bio-Pharma LLC ($340.26) |
| 2023 | $240.10 | 7 | Spinal Simplicity, LLC ($151.72) |
| 2022 | $340.06 | 15 | GRT US Holding, Inc. ($120.19) |
| 2021 | $458.58 | 16 | Medtronic, Inc. ($301.81) |
| 2020 | $131.58 | 1 | SPR Therapeutics, Inc ($131.58) |
| 2019 | $408.72 | 16 | Amgen Inc. ($211.54) |
| 2018 | $899.38 | 25 | BOSTON SCIENTIFIC CORPORATION ($390.51) |
| 2017 | $724.47 | 33 | Depomed, Inc. ($178.26) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: PAIN | ||||||
| 12/05/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $143.75 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/05/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $42.01 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/05/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Analgesic | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.13 | General |
| 11/12/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $18.03 | General |
| 11/06/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.25 | General |
| Category: Opioid Analgesic | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/10/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/09/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $69.84 | General |
| Category: PAIN | ||||||
| 10/07/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $10.69 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/17/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $114.59 | General |
| Category: PAIN | ||||||
| 06/07/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/30/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: PAIN | ||||||
| 05/21/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $23.43 | General |
| Category: Opioid Analgesic | ||||||
| 05/17/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $21.86 | General |
| Category: Pain management | ||||||
| 05/13/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/12/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $30.42 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.21 | General |
| Category: Opioid Analgesic | ||||||
| 03/26/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/25/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Analgesic | ||||||
| 03/21/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $50.25 | General |
| Category: PAIN | ||||||
| 02/02/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/25/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $67.06 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 939 | 8,076 | $527,115 | $174,774 |
| 2022 | 22 | 1,146 | 11,043 | $718,146 | $226,155 |
| 2021 | 23 | 1,323 | 9,355 | $822,161 | $257,326 |
| 2020 | 23 | 1,489 | 8,743 | $733,861 | $214,713 |
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 403 | 1,001 | $212,341 | $83,156 | 39.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 13 | 5,800 | $75,400 | $26,864 | 35.6% |
| J0475 | Injection, baclofen, 10 mg | Office | 2023 | 18 | 148 | $78,144 | $19,630 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 89 | 89 | $28,035 | $10,840 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 100 | 143 | $20,736 | $8,592 | 41.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 45 | 105 | $17,633 | $5,228 | 29.7% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 31 | 40 | $25,207 | $4,937 | 19.6% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 21 | 31 | $24,287 | $3,625 | 14.9% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 33 | 43 | $11,300 | $3,531 | 31.2% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 34 | 451 | $6,765 | $2,198 | 32.5% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 29 | 38 | $5,742 | $1,793 | 31.2% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2023 | 17 | 28 | $8,316 | $1,508 | 18.1% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 20 | 32 | $7,616 | $1,196 | 15.7% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 13 | 18 | $2,952 | $806.06 | 27.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 62 | 98 | $1,398 | $576.43 | 41.2% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 11 | 11 | $1,243 | $294.10 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 374 | 958 | $200,222 | $77,429 | 38.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 12 | 7,700 | $100,100 | $36,959 | 36.9% |
| J0475 | Injection, baclofen, 10 mg | Office | 2022 | 20 | 255 | $134,640 | $36,353 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 170 | 255 | $36,720 | $15,007 | 40.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 92 | 92 | $28,980 | $11,120 | 38.4% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 43 | 63 | $48,573 | $8,505 | 17.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 44 | 71 | $18,300 | $5,971 | 32.6% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2022 | 41 | 49 | $28,808 | $5,598 | 19.4% |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 2022 | 11 | 688 | $24,080 | $5,450 | 22.6% |
About Dr. Robert Leblond, MD
Dr. Robert Leblond, MD is a Physical Medicine & Rehabilitation healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699727008.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Leblond, MD has received a total of $4,117 in payments from pharmaceutical and medical device companies, with $913.89 received in 2024. These payments were reported across 138 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($4,117).
As a Medicare-enrolled provider, Leblond has provided services to 4,897 Medicare beneficiaries, totaling 37,217 services with total Medicare billing of $872,968. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Greenville, SC
- Active Since 05/16/2006
- Last Updated 02/06/2025
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1699727008
Products in Payments
- SPRINT PNS System (Device) $445.19
- SPECTRA WAVEWRITER (Device) $390.51
- NALOCET (Drug) $340.26
- Senza (Device) $217.69
- Aimovig (Biological) $211.54
- SYNCHROMED (Device) $180.71
- Accurian (Device) $179.90
- Nucynta (Drug) $170.05
- QUTENZA (Drug) $159.67
- Prialt (Drug) $158.49
- HA MINUTEMAN G3-R (Device) $151.72
- Senza Spinal Cord Stimulation System (Device) $121.91
- Qutenza (Drug) $120.19
- Zembrace (Drug) $109.94
- Gralise (Drug) $106.51
- OSTEOCOOL RF ABLATION (Device) $101.96
- PROLATE (Drug) $87.95
- Belbuca (Drug) $69.89
- RELISTOR ORAL (Drug) $55.77
- Morphabond ER (Drug) $55.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Greenville
Elizabeth Bagsby, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $33,384
Dr. Billy Smith, Md, MD
Physical Medicine & Rehabilitation — Payments: $14,556
Eleasa Hulon, Md, MD
Physical Medicine & Rehabilitation — Payments: $8,518
Dr. Jennifer Martin, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $3,390
Dr. Natalia Jolliff, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $3,173
Dr. Patrick Clegg, Do, DO
Physical Medicine & Rehabilitation — Payments: $2,031